Bowel (colorectal) cancer, Oesophageal cancer, Stomach cancer
Results
Other
This study looked at blood samples from people having chemotherapy. The study was open to people with cancer of the
We know that in most cases, cancers of the same type can be slightly different in their make up. This is because a variety of gene defects may cause the same disease. Not everyone with the same cancer has the same gene defect or protein make up. So people may respond to treatment differently even if they have the same type of cancer.
Researchers wanted to understand more about how genes or proteins were involved in cancer development, cancer spread and response to treatment. In this study, they looked at DNA and also used new technology called Protein Chip Profiling to examine hundreds of proteins from people having chemotherapy. The aims of the study were to
Look at any changes during cancer treatment in proteins and DNA in the liquid part of the blood (serum) and
See if these changes reflected what was happening to the cancer
Identify new characteristics (markers) in serum and hair follicle samples that may help predict outcome for future patients
Recruitment start: 27 October 2004
Recruitment end: 14 March 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Glasgow
Chief Scientist Office (CSO)
Greater Glasgow and Clyde Hospital Trust
Last reviewed: 11 Jun 2015
CRUK internal database number: 1424